bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2019: S A J J M A M F J
2018: D N O S

 
  Other news for:
Arthritis
 Resources from HONselect
Cimzia Approved for Inflammatory Arthritis

By Scott Roberts

FRIDAY, March 29, 2019 (HealthDay News) -- Cimzia (certolizumab pegol) injection has been approved by the U.S. Food and Drug Administration as the first sanctioned treatment for adults with non-radiographic axial spondyloarthritis (nr-axSpA), a type of arthritis.

Nr-axSpA causes inflammation in the spine, There is no visible damage seen on x-rays, so it is referred to as non-radiographic, the FDA explained in a news release.

The drug's effectiveness was determined in clinical studies involving 317 adults with nr-axSpA. When assessed for the drug's anti-inflammatory properties, responses were greater for patients treated with Cimzia, compared to those treated with a placebo, the agency said.

The drug's label includes a boxed warning about users' increased risk of serious infections, including tuberculosis, bacterial sepsis (blood infection) and dangerous fungal infections. Cimzia should be discontinued if a user develops a serious infection, the FDA advised.

Doctors should test potential users for TB before starting the drug, the agency said.

The boxed warning also advises that lymphoma (cancer in blood cells) and other types of cancer, some fatal, have been reported in children and adolescents treated with this class of drug, known as tumor necrosis factor (TNF) blockers. Cimzia is not approved for children or teens, the FDA stressed.

Cimzia, first approved in 2008, also is sanctioned for certain adults with Crohn's disease, moderate-to-severe rheumatoid arthritis, active ankylosing spondylitis (AS) and moderate-to-severe plaque psoriasis.

The drug is produced by Belgium-based UCB.

More information

Visit the FDA to learn more.

Copyright © 2019 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=744436

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Arthritis
Infection
Adult
Neoplasms
Blood
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact